Vasopressin release from rat medial basal hypothalamus induced in vitro by angiotensin.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 7106181)

Published in Eur J Pharmacol on May 21, 1982

Authors

W Knepel, H Anhut, D Nutto, A Holland, D K Meyer

Articles citing this

Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent. Am J Physiol Regul Integr Comp Physiol (2013) 1.56

Articles by these authors

Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) (1981) 3.07

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry (1990) 2.22

Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther (2007) 1.67

Dental trauma in anaesthesia. Can J Anaesth (1989) 1.51

Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry (1989) 1.44

Alpha-cell-specific expression of the glucagon gene is conferred to the glucagon promoter element by the interactions of DNA-binding proteins. Mol Cell Biol (1988) 1.35

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res (1981) 1.27

Phenotypic and molecular characterization of three clinical isolates of Mycobacterium interjectum. J Clin Microbiol (1997) 1.25

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology (1998) 1.24

Prader-Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey. Br J Psychiatry (2002) 1.14

Influence of isoproterenol, hydralazine and phentolamine on the renin activity of plasma and renal cortex of rats. Eur J Pharmacol (1970) 1.14

Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet (1981) 1.13

Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. J Intellect Disabil Res (2004) 1.12

Effect of carbenoxolone on prostaglandin synthesis and degradation. J Pharm Pharmacol (1976) 1.12

A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience (1999) 1.09

Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. Arch Neurol (1988) 1.09

Self-harm, capacity, and refusal of treatment: implications for emergency medical practice. A prospective observational study. Emerg Med J (2005) 1.05

Radioimmunological determination of thromboxane release in cardiac anaphylaxis. Eur J Pharmacol (1977) 1.04

Distinct properties of the cAMP-responsive element of the rat insulin I gene. J Biol Chem (1994) 1.01

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Rehabilitation. Stroke (1997) 1.00

A four year prospective study of age-related cognitive change in adults with Down's syndrome. Psychol Med (1998) 0.99

Neosynthesis and activation of Rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated Rho. J Biol Chem (1999) 0.99

Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis. Prostaglandins (1978) 0.97

Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab (2001) 0.97

Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats. Eur J Pharmacol (1972) 0.96

The mechanism of the drinking response to some hypotensive drugs: activation of the renin-angiotensin system by direct or reflex-mediated stimulation of -receptors. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.96

Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol Pharmacol (1995) 0.96

Involvement of the Ca(2+)-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. J Biol Chem (1995) 0.96

Fragile X mental retardation and the iduronate sulphatase locus: testing Laird's model of fra(X) inheritance. Am J Med Genet (1992) 0.96

Identical triplets: non-identical psychosis? Br J Psychiatry (1982) 0.95

Heterodimeric Pbx-Prep1 homeodomain protein binding to the glucagon gene restricting transcription in a cell type-dependent manner. J Biol Chem (2000) 0.94

Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J Biol Chem (1993) 0.94

Cholecystokinin octapeptide in the rat hypothalamo-neurohypophysial system. Nature (1980) 0.94

A diurnal rhythm of incorporation of L-[3H] leucine in myocardium of the rat. Recent Adv Stud Cardiac Struct Metab (1975) 0.94

Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia (2007) 0.94

Gene expression of the small GTP-binding proteins RhoA, RhoB, Rac1, and Cdc42 in adult rat brain. Brain Res Mol Brain Res (1997) 0.93

Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.93

Gene-specific transcriptional activity of the insulin cAMP-responsive element is conferred by NF-Y in combination with cAMP response element-binding protein. J Biol Chem (1998) 0.93

Release of 15-keto-13, 14-dihydro-thromboxane B2 and prostaglandin D2 during anaphylaxis as measured by radioimmunoassay. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.92

Membrane depolarization and calcium influx induce glucagon gene transcription in pancreatic islet cells through the cyclic AMP-responsive element. J Biol Chem (1993) 0.91

Use of a portable computer program to assist behavioral treatment in a case of obsessive compulsive disorder. J Behav Ther Exp Psychiatry (1988) 0.91

Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol (1996) 0.91

Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem (1991) 0.90

Prolactin cell autoantibodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1985) 0.89

[Inhibition by nephrectomy of drinking induced by hypotensive agents in rats]. Experientia (1971) 0.88

Characterization of a novel protein kinase C response element in the glucagon gene. Mol Cell Biol (1997) 0.88

Characterization of a novel calcium response element in the glucagon gene. J Biol Chem (1999) 0.88

Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma. Eur J Pharmacol (1981) 0.87

Effects of ruminal insufflation on renal function of conscious goats and calves. Am J Vet Res (1967) 0.87

Inhibition of membrane depolarisation-induced transcriptional activity of cyclic AMP response element binding protein (CREB) by the dual-leucine-zipper-bearing kinase in a pancreatic islet beta cell line. Diabetologia (2005) 0.86

Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung (1993) 0.86

Role of vasopressin in the ACTH response to isoprenaline. Eur J Pharmacol (1982) 0.86

Stimulation of receptors of gamma-aminobutyric acid modulates the release of cholecystokinin-like immunoreactivity from slices of rat neostriatum. Br J Pharmacol (1986) 0.86

The oxidation and subcellular distribution of 14 C-palmitate in experimental acute myocardial infarction. Cardiology (1971) 0.86

Tissue-specific transcriptional activity of a pancreatic islet cell-specific enhancer sequence/Pax6-binding site determined in normal adult tissues in vivo using transgenic mice. Mol Endocrinol (1999) 0.86

Use of semantic context by patients with Alzheimer's disease. Psychol Aging (1986) 0.86

The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.85

Deafferentation studies on the glutamic acid decarboxylase content of the supraoptic nucleus of the rat. Brain Res (1980) 0.85

Effect of isoprenaline and trimethidinium on the plasma vasopressin concentration in conscious rats. Arch Int Pharmacodyn Ther (1980) 0.85

Mental disorders and problematic behaviours in people with intellectual disability: future directions for research. J Intellect Disabil Res (1997) 0.85

Domesticated farm animals in medical research. Ann N Y Acad Sci (1968) 0.84

Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo. Am J Psychiatry (1990) 0.84

Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man. Horm Metab Res (1986) 0.84

Inhibition of the transport of d-tubocurarine from blood to bile by k-strophantoside in the isolated perfused rat liver. Eur J Pharmacol (1968) 0.84

Differential expression of the small GTP-binding proteins RhoA, RhoB, Cdc42u and Cdc42b in developing rat neocortex. Brain Res Mol Brain Res (1999) 0.83

A study of the influence of different genotypes on the physical and behavioral phenotypes of children and adults ascertained clinically as having PWS. Clin Genet (2002) 0.83

Radioimmunological determination of prostaglandin D2 synthesis in human thrombocytes. Experientia (1978) 0.83

Origin of the cholecystokinin-containing fibers in the rat caudatoputamen. Science (1982) 0.83

Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Endocrinology (1984) 0.83

Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release. Pflugers Arch (1980) 0.83

Insulin responsiveness of the glucagon gene conferred by interactions between proximal promoter and more distal enhancer-like elements involving the paired-domain transcription factor Pax6. J Biol Chem (2000) 0.83

The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin Otolaryngol Allied Sci (1994) 0.83

On the mechanism of the vasopressin-induced inhibition of renin release. Horm Metab Res (1982) 0.83

Characterization of "high-affinity" [3H]ouabain binding in the rat central nervous system. J Neurochem (1985) 0.83

Regional distribution of arachidonic acid metabolites in rat brain following convulsive stimuli. Prostaglandins (1981) 0.83

Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line. Endocrinology (1996) 0.83

Properties and the cytoskeletal control of Ca(++)-independent large conductance K+ channels in neonatal rat hippocampal neurons. J Membr Biol (1998) 0.82

CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study. Brain Res (1981) 0.82

Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure. Diabetologia (2008) 0.82

Detection and characterisation of neurotransmitters, particularly peptides, in the gastrointestinal tract. Scand J Gastroenterol Suppl (1982) 0.82

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. Am J Psychiatry (1989) 0.82

Neurons are generated in confluent astroglial cultures of rat neonatal neocortex. Neuroscience (1997) 0.82

Influence of serotonin on water intake and the renin-angiotensin system in the rat. Arch Int Pharmacodyn Ther (1974) 0.81

Comparison of graded versus constant treadmill test protocols for quantifying intermittent claudication. Vasc Med (1997) 0.81

Top concentrations of dynorphin-like immunoreactivity in fractions of rat anterior pituitary cells enriched in gonadotrophs. Life Sci (1986) 0.81

Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone. Eur J Pharmacol (1982) 0.81

Naloxone promotes stimulus-evoked vasopressin release in vivo. Eur J Pharmacol (1980) 0.81

[Contrast-enhancend sonography (CEUS) in pneumonia: typical patterns and clinical value - a retrospective study on n = 50 patients]. Ultraschall Med (2011) 0.81

Dopamine modulates cholecystokinin release in neostriatum. Nature (1983) 0.81

GRF elevates cytosolic free calcium concentration in rat anterior pituitary cells. Am J Physiol (1987) 0.81

Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context. Mol Pharmacol (1999) 0.81

Evidence for inhibition by beta-endorphin of vasopressin release during foot shock-induced stress in the rat. Neuroendocrinology (1982) 0.81

Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy. Arch Intern Med (1996) 0.81

In vitro CRF activity of vasopressin analogs is not related to pressor activity. Eur J Pharmacol (1983) 0.81